BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 15981233)

  • 1. Veno-occlusive disease of the liver associated with chronic myelomonocytic leukemia treated with vincristine and standard doses of cytarabine.
    Boula AM; Mantadakis E; Xilouri IM; Christoforidou AV; Foudoulakis AM; Samonis G
    Am J Hematol; 2005 Jul; 79(3):216-9. PubMed ID: 15981233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Veno-occlusive disease in pediatric patients receiving actinomycin D and vincristine only for the treatment of rhabdomyosarcoma.
    Sulis ML; Bessmertny O; Granowetter L; Weiner M; Kelly KM
    J Pediatr Hematol Oncol; 2004 Dec; 26(12):843-6. PubMed ID: 15591910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hepatic veno-occlusive disease--simulating acute abdomen in chemotherapy of Wilms' tumors].
    Tröbs RB; Rothe K; Meier T
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():1112-4. PubMed ID: 9101794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Veno-occlusive disease in a male patient with Marfan syndrome and common acute lymphoblastic leukemia during induction therapy.
    Kraemer DM; Waschke J; Kunzmann V; Wilhelm M
    Ann Hematol; 2003 Jul; 82(7):444-7. PubMed ID: 12761649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Veno-occlusive disease in a child with rhabdomyosarcoma after conventional chemotherapy: report of a case and review of the literature.
    Cecen E; Uysal KM; Ozguven A; Gunes D; Irken G; Olgun N
    Pediatr Hematol Oncol; 2007 Dec; 24(8):615-21. PubMed ID: 18092252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose methylprednisolone treatment of hepatic veno-occlusive disease in a child with Wilms tumor.
    Akyüz C; CaClar K; Emir S; Büyükpamukçu M
    Pediatr Hematol Oncol; 2003 Jun; 20(4):345-9. PubMed ID: 12746168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venoocclusive liver disease (VOD) as a complication of Wilms' tumour management in the series of consecutive 206 patients.
    Czauderna P; Katski K; Kowalczyk J; Kurylak A; Lopatka B; Skotnicka-Klonowicz G; Sawicz-Birkowska K; Godziński J
    Eur J Pediatr Surg; 2000 Oct; 10(5):300-3. PubMed ID: 11194540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Veno-occlusive disease of the liver in a child after chemotherapy for brain tumor.
    Elli M; Pinarli FG; Dagdemir A; Acar S
    Pediatr Blood Cancer; 2006 Apr; 46(4):521-3. PubMed ID: 16317738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Veno-occlusive disease of the liver during induction therapy for acute lymphoblastic leukemia.
    Papadopoulos A; Ntaios G; Kaiafa G; Girtovitis F; Saouli Z; Kontoninas Z; Diamantidis MD; Savopoulos C; Hatzitolios A
    Int J Hematol; 2008 Nov; 88(4):441-442. PubMed ID: 18839274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venoocclusive disease of the liver after chemotherapy with vincristine, actinomycin D, and cyclophosphamide for the treatment of rhabdomyosarcoma. A report of the Intergroup Rhabdomyosarcoma Study Group. Childrens Cancer Group, the Pediatric Oncology Group, and the Pediatric Intergroup Statistical Center.
    Ortega JA; Donaldson SS; Ivy SP; Pappo A; Maurer HM
    Cancer; 1997 Jun; 79(12):2435-9. PubMed ID: 9191535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatal hepatic veno-occlusive disease with fibrinolysis as the cause of death during preoperative chemotherapy for nephroblastoma.
    Culić S; de Kraker J; Kuljis D; Kuzmić I; Saraga M; Culić V; Balarin L; Primorac D
    Med Pediatr Oncol; 1998 Sep; 31(3):175-6. PubMed ID: 9722902
    [No Abstract]   [Full Text] [Related]  

  • 12. Fatal hepatic veno-occlusive disease in an adult patient with Wilms' tumour.
    Uygun K; Kocak Z; Cicin I; Caloglu M
    Clin Oncol (R Coll Radiol); 2003 Sep; 15(6):366. PubMed ID: 14524493
    [No Abstract]   [Full Text] [Related]  

  • 13. Veno-occlusive disease in pediatric patients affected by Wilms tumor.
    Cesaro S; Spiller M; Sartori MT; Alaggio R; Peruzzo M; Saggiorato G; Bisogno G
    Pediatr Blood Cancer; 2011 Aug; 57(2):258-61. PubMed ID: 21246705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Veno-occlusive disease of the liver in children treated for Wilms tumor.
    Bisogno G; de Kraker J; Weirich A; Masiero L; Ludwig R; Tournade MF; Carli M
    Med Pediatr Oncol; 1997 Oct; 29(4):245-51. PubMed ID: 9251728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Veno-occlusive disease of the liver after combined adjuvant chemotherapy for a 1-year-old boy with rhabdomyosarcoma: potential usefulness of the gabexate mesylate (FOY).
    Adachi N; Matsuda I
    J Pediatr Gastroenterol Nutr; 1992 Apr; 14(3):314-8. PubMed ID: 1619537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effective treatment of CMMoL with F-COP (epirubicine, cyclophosphamide, vincristine, prednisolone) therapy].
    Takagi S
    Rinsho Ketsueki; 1992 Sep; 33(9):1248-51. PubMed ID: 1433946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An unusual presentation of infantile fibrosarcoma in a male newborn.
    Gülhan B; Küpeli S; Yalçin B; Akyüz C; Büyükpamukçu M
    Am J Perinatol; 2009 May; 26(5):331-3. PubMed ID: 19067284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe veno-occlusive disease in an overweight infant with a renal tumor.
    Faqih N; Hazin R; Barbar M; Ismael T; Al-Gharabli F; Sultan I
    Pediatr Blood Cancer; 2009 Jul; 52(7):900. PubMed ID: 19213075
    [No Abstract]   [Full Text] [Related]  

  • 19. Sequential salvage chemotherapy for recurrent intracranial hemangiopericytoma.
    Chamberlain MC; Glantz MJ
    Neurosurgery; 2008 Oct; 63(4):720-6; author reply 726-7. PubMed ID: 18981882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic veno-occlusive disease after neoadjuvant treatment of colorectal liver metastases with oxaliplatin: a lesson of the month.
    Schouten van der Velden AP; Punt CJ; Van Krieken JH; Derleyn VA; Ruers TJ
    Eur J Surg Oncol; 2008 Mar; 34(3):353-5. PubMed ID: 17207961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.